{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:55:37Z","timestamp":1759938937684},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1097\/01.ju.0000138472.16876.8d","type":"journal-article","created":{"date-parts":[[2004,10,8]],"date-time":"2004-10-08T08:02:54Z","timestamp":1097222574000},"page":"2059-2064","source":"Crossref","is-referenced-by-count":32,"title":["DEMONSTRATION OF BLADDER SELECTIVE MUSCARINIC RECEPTOR BINDING BY INTRAVESICAL OXYBUTYNIN TO TREAT OVERACTIVE BLADDER"],"prefix":"10.1097","volume":"172","author":[{"given":"TOMOMI","family":"OKI","sequence":"first","affiliation":[{"name":"From the Department of Biopharmaceutical Sciences and COE Program in the 21st Century, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka (TO, RK, SY) and Department of Urology, Tottori University Faculty of Medicine (MS, IM), Yonago, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RYOHEI","family":"KIMURA","sequence":"additional","affiliation":[{"name":"From the Department of Biopharmaceutical Sciences and COE Program in the 21st Century, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka (TO, RK, SY) and Department of Urology, Tottori University Faculty of Medicine (MS, IM), Yonago, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MOTOAKI","family":"SAITO","sequence":"additional","affiliation":[{"name":"From the Department of Biopharmaceutical Sciences and COE Program in the 21st Century, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka (TO, RK, SY) and Department of Urology, Tottori University Faculty of Medicine (MS, IM), Yonago, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"IKUO","family":"MIYAGAWA","sequence":"additional","affiliation":[{"name":"From the Department of Biopharmaceutical Sciences and COE Program in the 21st Century, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka (TO, RK, SY) and Department of Urology, Tottori University Faculty of Medicine (MS, IM), Yonago, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHIZUO","family":"YAMADA","sequence":"additional","affiliation":[{"name":"From the Department of Biopharmaceutical Sciences and COE Program in the 21st Century, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka (TO, RK, SY) and Department of Urology, Tottori University Faculty of Medicine (MS, IM), Yonago, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1097\/01.ju.0000138472.16876.8d_bib1","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0022-5347(17)36663-6","article-title":"The pharmacokinetics of intravesical and oral oxybutynin chloride","volume":"148","author":"Massad","year":"1992","journal-title":"J Urol"},{"key":"10.1097\/01.ju.0000138472.16876.8d_bib2","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0022-5347(01)62828-3","article-title":"Intravesical oxybutynin for neurogenic bladder dysfunction: less systematic side effects due to reduced first pass metabolism","volume":"160","author":"Buyse","year":"1998","journal-title":"J Urol"},{"key":"10.1097\/01.ju.0000138472.16876.8d_bib3","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0022-5347(17)37845-X","article-title":"The use of intravesical oxybutynin chloride in children with neurogenic bladder","volume":"146","author":"Greenfield","year":"1991","journal-title":"J Urol"},{"key":"10.1097\/01.ju.0000138472.16876.8d_bib4","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0090-4295(93)90098-U","article-title":"Intravesical oxybutynin chloride: experience with 42 patients","volume":"41","author":"Weese","year":"1993","journal-title":"Urology"},{"key":"10.1097\/01.ju.0000138472.16876.8d_bib5","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/S0022-5347(17)35130-3","article-title":"The use of intravesical oxybutynin chloride in patients with detrusor hypertonicity and detrusor hyperreflexia","volume":"151","author":"Kasabian","year":"1994","journal-title":"J Urol"},{"key":"10.1097\/01.ju.0000138472.16876.8d_bib6","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/S0022-5347(05)65540-1","article-title":"Intravesical oxybutynin: mode of action assessed by passive diffusion and electromotive administration with pharmacokinetics of oxybutynin and N-desethyl oxybutynin","volume":"166","author":"Di Stasi","year":"2001","journal-title":"J Urol"},{"key":"10.1097\/01.ju.0000138472.16876.8d_bib7","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/1520-6777(2000)19:6<683::AID-NAU6>3.0.CO;2-R","article-title":"Treatment of overactive bladder with modified intravesical oxybutynin choloride","volume":"19","author":"Saito","year":"2000","journal-title":"Neurourol Urodyn"},{"key":"10.1097\/01.ju.0000138472.16876.8d_bib8","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0014-2999(86)90697-7","article-title":"Dicyclomine, benzhexol and oxybutynin distinguish between subclasses of muscarinic binding sites","volume":"123","author":"Nilvebrant","year":"1986","journal-title":"Eur J Pharmacol"},{"key":"10.1097\/01.ju.0000138472.16876.8d_bib9","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2165\/00002512-199506030-00007","article-title":"Oxybutynin. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability","volume":"6","author":"Yarker","year":"1995","journal-title":"Drugs Aging"},{"key":"10.1097\/01.ju.0000138472.16876.8d_bib10","first-page":"239","article-title":"Integration of pharmacokinetics and pharmacodynamics in drug development\u2014in vivo receptor occupancy by calcium antagonist and angiotensin II receptor antagonist","volume":"4","author":"Yamada","year":"1998","journal-title":"Curr Topics Pharmacol"},{"key":"10.1097\/01.ju.0000138472.16876.8d_bib11","first-page":"176","article-title":"Characterization of alpha-1 adrenergic receptors in the heart using [3H]WB4101: effect of 6-hydroxydomine treatment","volume":"215","author":"Yamada","year":"1980","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1097\/01.ju.0000138472.16876.8d_bib12","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"10.1097\/01.ju.0000138472.16876.8d_bib13","first-page":"1148","article-title":"Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain","volume":"255","author":"Ehlert","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1097\/01.ju.0000138472.16876.8d_bib14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1476-5381.1995.tb14928.x","article-title":"The receptor occupation and plasma concentration of NKY-722, a water-soluble dihydropyridine-type calcium antagonist, in spontaneously hypertensive rats","volume":"114","author":"Uchida","year":"1995","journal-title":"Br J Pharmacol"},{"key":"10.1097\/01.ju.0000138472.16876.8d_bib15","first-page":"417","article-title":"Effects of the anticholinergic drug prifinium bromide on urinary bladder contractions in rat in vivo and in guinea-pig in vitro","volume":"41","author":"Terai","year":"1991","journal-title":"Arzneimittelforschung"},{"key":"10.1097\/01.ju.0000138472.16876.8d_bib16","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0022-5347(01)66518-2","article-title":"Urodynamic effects of intravesical oxybutynin chloride in conscious rats","volume":"155","author":"Yokoyama","year":"1996","journal-title":"J Urol"},{"key":"10.1097\/01.ju.0000138472.16876.8d_bib17","first-page":"120","article-title":"Brain nicotinic acetylcholine receptors. Biochemical characterization by neosurugatoxin","volume":"28","author":"Yamada","year":"1985","journal-title":"Mol Pharmacol"},{"key":"10.1097\/01.ju.0000138472.16876.8d_bib18","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3109\/00498259209053145","article-title":"Measurement of oxybutynin and its N-desethyl metabolite in plasma, and its application to pharmacokinetic studies in young, elderly and frail elderly volunteers","volume":"22","author":"Hughes","year":"1992","journal-title":"Xenobiotica"},{"key":"10.1097\/01.ju.0000138472.16876.8d_bib19","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0022-5347(01)65148-6","article-title":"Comparison of oxybutynin and its active metabolite, N-desethyl-oxybutynin, in the human detrusor and parotid gland","volume":"157","author":"Waldeck","year":"1997","journal-title":"J Urol"},{"key":"10.1097\/01.ju.0000138472.16876.8d_bib20","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/nau.1930090211","article-title":"Relaxation of intestinal bladders by intravesical oxybutynin chloride","volume":"9","author":"Mohler","year":"1990","journal-title":"Neurourol Urodyn"},{"key":"10.1097\/01.ju.0000138472.16876.8d_bib21","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/sj.bjp.0703068","article-title":"Urothelium-derived inhibitory factor(s) influences on detrusor muscle contractility in vitro.","volume":"129","author":"Hawthorn","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1097\/01.ju.0000138472.16876.8d_bib22","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1046\/j.1474-8673.2002.00258.x","article-title":"Muscarinic receptors of the urinary bladder: detrusor, urothelial and prejunctional","volume":"22","author":"Chess-Williams","year":"2002","journal-title":"Auton Autacoid Pharmacol"},{"key":"10.1097\/01.ju.0000138472.16876.8d_bib23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.urology.2003.11.003","article-title":"Management of detrusor dysfunction in the elderly: changes in acetylcholine and adenosine triphosphate release during aging","volume":"63","author":"Yoshida","year":"2004","journal-title":"Urology"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0022534705609287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0022534705609287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1097\/01.ju.0000138472.16876.8d","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T06:13:46Z","timestamp":1651212826000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1097\/01.ju.0000138472.16876.8d"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["10.1097\/01.ju.0000138472.16876.8d"],"URL":"https:\/\/doi.org\/10.1097\/01.ju.0000138472.16876.8d","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,11]]}}}